Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

VALUATIONS - Current Issues in Biotech and Pharma. Global Life Science expert and former manager of the Axa Framlington Biotech Fund, Andy Smith, looks at the current issues surrounding biotech and pharma companies.

In this first talk, Andy discusses valuations of profitable companies relative to history. The discussion explores the PE values of various companies and how these have changed over time.
 
Andy will be giving a weekly video webcast on various aspects of the biotech space at 3B NEXUS business and investor video portal. Your clients might be interested to hear Andy's views and conclusions on the topics covered. 
 
Next week, Andy will be addressing clinical trials and cancer and in the coming weeks discussing vaccines, antibiotics and cancer vaccines. 
 
Speaker:          Dr. Andy Smith
Date:                September 22, 2010
Time:               1500 LONDON (NYSE:BST) - available on-demand immediately after.
Place:               Follow the link to www.3bnexus.com starting from 1500 LONDON (BST) to watch this broadcast and on-demand any time after.
 
Andy's profile and video transcript will also be available for download.
 
You can broadcast live or upload your own investor and corporate videos. Free WebTV is provided for your websites. 3B NEXUS.